1 – 10 of 1496
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers Apoptosis
(
- Contribution to journal › Article
-
Mark
Apolipoprotein M delays the development of atherosclerosis by regulating autophagy and mitochondrial function
(
- Contribution to journal › Article
-
Mark
Comprehensive biobanking strategy with clinical impact at the European Cancer Moonshot Lund Center
(
- Contribution to journal › Scientific review
-
Mark
Design, synthesis, and evaluation of a novel fluorescent probe for competitive fluorescence polarization assay to screen galectin-8 inhibitors
2025) In Acta Pharmaceutica(
- Contribution to journal › Article
-
Mark
Nanomolar inhibitor of the galectin-8 N-terminal domain binds via a non-canonical cation-π interaction
(
- Contribution to journal › Article
-
Mark
Role of Structural Modifications in Peptidomimetic Compounds as Potential Antimicrobial Agents against Staphylococcus aureus and Streptococcus pyogenes: Balancing Bioavailability, Safety, and Antimicrobial Activity
2025) In ACS Omega(
- Contribution to journal › Article
-
Mark
Synthesis, conformational analysis and biological activity of xylopyranosyl sulfur-containing glycosides : dependence of sulfur atom configuration
(
- Contribution to journal › Article
- 2024
-
Mark
Achieving efficient clonal beta cells transfection using nanostraw/nanopore-assisted electroporation
(
- Contribution to journal › Article
-
Mark
Resolution of ribosomal stalling by EF-P and ABCF ATPases YfmR and YkpA/YbiT
(
- Contribution to journal › Article
-
Mark
Galectin-8N-Selective 4-Halophenylphthalazinone-Galactals Double π-Stack in a Unique Pocket
(
- Contribution to journal › Article